PharmaMar renews alliance with Janssen, allowing US-based company to market anti-tumour Yondelis in the US while Spain-based company will do it in 40 other countries
PharmaMar renueva su acuerdo con Janssen, por el que la estadounidense comercializará el antitumoral Yondelis en EEUU y la española en otros 40 países
Intel ID : 275617
Relevant Documents
| Press Release | 26 Aug 2019 | PharmaMar_Nota_de_Prensa_2019.pdf | ES |
|
| Intel ID | 275617 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - PharmaMar
(31 Dec 2021) |
Revenue: EUR 234,42m EBITDA: EUR 97,85m Net Debt: EUR 444,07m |
|
| Date |
 |
|
| Country | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
 |
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Ultimate Owner (Buyer)
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.04.03 Personal Care Products 15 Consumer Products & Services / 15.04 Consumer Nondurables 30.02.01 Diagnostic & Testing Substances 30 Healthcare / 30.02 Healthcare Equipment & Supplies 30.02.03 Healthcare Product Distributors 30 Healthcare / 30.02 Healthcare Equipment & Supplies 30.02.04 Medical Diagnostic Equipment 30 Healthcare / 30.02 Healthcare Equipment & Supplies 30.02.07 Surgical Equipment 30 Healthcare / 30.02 Healthcare Equipment & Supplies 55.02.04 Pharmaceutical & Personal Care Chemicals 55 Raw Materials & Natural Resources / 55.02 Chemicals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.